Details of the Drug | DrugMAP

General Information of Drug (ID: DMRR5P0)

Drug Name

DCCR

Synonyms

Diazoxide choline controlled-release

Indication

Disease Entry	ICD 11	Status	REF
Prader-Willi syndrome	LD90.3	Phase 3	[1]
Dyslipidemia	5C80-5C81	Phase 2	[2]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C13H21ClN3O3S+
Canonical SMILES: CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl.C[N+](C)(C)CCO
InChI: 1S/C8H7ClN2O2S.C5H14NO/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5;1-6(2,3)4-5-7/h2-4H,1H3,(H,10,11);7H,4-5H2,1-3H3/q;+1
InChIKey: HDPYPMDYNYTKHI-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 66625981
TTD ID: D0D9VE

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT03440814) A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01211847) Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia. U.S. National Institutes of Health.